Even a JRPG's combat system needs to evolve alongside its characters if you want to go from rat hunting to god slaying.

Shares in Eli Lilly were tracking down this morning after the company revealed data on its oral weight-loss candidate, orforglipron, that seems to have once again disappointed investors. The results ...